🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
316,13 USD
Máx. histórico
322,75
5 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,05%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+0,83%
Cierre anterior
313,52
Rango de hoy
309,86 – 319,18
Volumen hoy
179.912
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 124,46 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 2 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/03/2021 | 87,74 | 96,52 | 86,71 | 95,89 | +7,43% | 11,18% | 326.211 |
| 24/03/2021 | 93,87 | 97,82 | 89,21 | 89,26 | -4,60% | 9,17% | 267.541 |
| 23/03/2021 | 102,25 | 102,80 | 92,33 | 93,56 | -8,85% | 10,24% | 414.856 |
| 22/03/2021 | 100,67 | 104,12 | 100,67 | 102,65 | +2,88% | 3,43% | 247.664 |
| 19/03/2021 | 96,79 | 102,03 | 96,33 | 99,78 | +3,26% | 5,89% | 1.527.018 |
| 18/03/2021 | 103,64 | 104,56 | 96,44 | 96,63 | -6,68% | 7,83% | 369.492 |
| 17/03/2021 | 100,75 | 104,30 | 98,43 | 103,54 | +2,13% | 5,83% | 233.878 |
| 16/03/2021 | 102,08 | 105,41 | 100,08 | 101,38 | -0,44% | 5,22% | 280.365 |
| 15/03/2021 | 103,62 | 107,42 | 100,88 | 101,83 | -0,93% | 6,31% | 321.241 |
| 12/03/2021 | 99,05 | 103,79 | 95,77 | 102,79 | +5,13% | 8,09% | 501.579 |
| 11/03/2021 | 92,67 | 104,30 | 92,50 | 97,78 | +6,65% | 12,74% | 730.968 |
| 10/03/2021 | 96,15 | 98,50 | 90,25 | 91,68 | -3,50% | 8,58% | 379.590 |
| 09/03/2021 | 89,03 | 96,47 | 89,03 | 95,00 | +9,29% | 8,36% | 554.157 |
| 08/03/2021 | 89,64 | 91,97 | 85,61 | 86,92 | -3,50% | 7,10% | 362.278 |
| 05/03/2021 | 88,18 | 91,80 | 84,43 | 90,08 | +1,90% | 8,36% | 577.401 |
| 04/03/2021 | 92,12 | 93,26 | 86,38 | 88,40 | -4,11% | 7,48% | 426.879 |
| 03/03/2021 | 96,31 | 96,49 | 90,89 | 92,20 | -3,32% | 5,82% | 407.803 |
| 02/03/2021 | 96,16 | 100,57 | 95,25 | 95,36 | -2,34% | 5,54% | 659.795 |
| 01/03/2021 | 94,04 | 98,55 | 91,17 | 97,64 | +5,60% | 7,84% | 411.650 |
| 26/02/2021 | 91,89 | 95,90 | 89,31 | 92,46 | -1,32% | 7,17% | 486.350 |
| 25/02/2021 | 91,92 | 98,89 | 89,68 | 93,71 | +2,64% | 10,02% | 854.720 |
| 24/02/2021 | 88,62 | 91,36 | 86,14 | 91,29 | +3,65% | 5,89% | 422.871 |
| 23/02/2021 | 85,09 | 91,24 | 81,73 | 88,07 | +0,89% | 11,17% | 765.753 |
| 22/02/2021 | 88,77 | 91,27 | 86,49 | 87,30 | -2,05% | 5,38% | 477.694 |
| 19/02/2021 | 90,59 | 92,68 | 88,30 | 89,13 | -1,39% | 4,84% | 502.541 |
| 18/02/2021 | 92,05 | 93,23 | 89,72 | 90,39 | -2,65% | 3,82% | 522.418 |
| 17/02/2021 | 97,47 | 100,09 | 90,46 | 92,84 | -7,59% | 9,88% | 1.455.203 |
| 16/02/2021 | 112,43 | 112,43 | 96,96 | 100,47 | -6,62% | 13,76% | 1.364.474 |
| 12/02/2021 | 111,83 | 114,59 | 105,31 | 107,59 | -4,21% | 8,30% | 936.312 |
| 11/02/2021 | 131,07 | 132,10 | 111,75 | 112,31 | -14,62% | 15,53% | 971.097 |